Detalles de la búsqueda
1.
Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): a randomised, open-label, multicentre, phase 3 trial.
Lancet
; 401(10390): 1773-1785, 2023 05 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-37086745
2.
Improving outcomes for patients with diffuse large B-cell lymphoma.
CA Cancer J Clin
; 60(6): 393-408, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-21030533
3.
Outcomes following watchful waiting for stage II-IV follicular lymphoma patients in the modern era.
Br J Haematol
; 172(5): 724-34, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26729445
4.
A phase II study of bortezomib added to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone in patients with previously untreated indolent non-Hodgkin's lymphoma.
Br J Haematol
; 171(4): 539-46, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26248505
5.
The use and effectiveness of rituximab maintenance in patients with follicular lymphoma diagnosed between 2004 and 2007 in the United States.
Cancer
; 120(12): 1830-7, 2014 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24668580
6.
Mobilization of hematopoietic progenitors from normal donors using the combination of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor results in fewer plasmacytoid dendritic cells in the graft and enhanced donor T cell engraftment with Th1 polarization: results from a randomized clinical trial.
Biol Blood Marrow Transplant
; 19(3): 460-7, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23201472
7.
A phase 1 dose escalation study of bortezomib combined with rituximab, cyclophosphamide, doxorubicin, modified vincristine, and prednisone for untreated follicular lymphoma and other low-grade B-cell lymphomas.
Cancer
; 118(14): 3538-48, 2012 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22535574
8.
Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia.
Blood
; 115(13): 2578-85, 2010 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19965662
9.
Racial differences in the presentation and outcomes of diffuse large B-cell lymphoma in the United States.
Cancer
; 117(11): 2530-40, 2011 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24048801
10.
Idiotype vaccine strategies for treatment of follicular lymphoma.
Future Oncol
; 7(1): 111-22, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21174542
11.
Perifosine synergistically enhances TRAIL-induced myeloma cell apoptosis via up-regulation of death receptors.
Clin Cancer Res
; 14(16): 5090-8, 2008 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-18698026
12.
Considerations in the initial management of follicular lymphoma.
Community Oncol
; 9(11): S53-S60, 2012 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23544009
13.
Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery.
Mol Cancer Ther
; 5(8): 1909-17, 2006 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-16928810
14.
Novel treatment approaches for patients with multiple myeloma.
Clin Lymphoma Myeloma
; 6(4): 281-8, 2006 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-16507205
15.
A Phase 2 Trial of Fludarabine Combined With Subcutaneous Alemtuzumab for the Treatment of Relapsed/Refractory B-Cell Chronic Lymphocytic Leukemia.
Clin Lymphoma Myeloma Leuk
; 15(11): 694-8, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26385641
16.
Comparison of the effectiveness of frontline chemoimmunotherapy regimens for follicular lymphoma used in the United States.
Leuk Lymphoma
; 56(5): 1295-302, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25263322
17.
Combination of GM-CSF With Fludarabine-Containing Regimens in Chronic Lymphocytic Leukemia and Indolent Non-Hodgkin Lymphoma.
Clin Lymphoma Myeloma Leuk
; 15(9): 514-8, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26297176
18.
Intensive chemotherapy and consolidation with high dose therapy and autologous stem cell transplant in patients with mantle cell lymphoma.
Leuk Lymphoma
; 56(2): 383-9, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24828864
19.
The role of chemotherapy in managing chronic lymphocytic leukemia: optimizing combinations with targeted therapy.
Expert Rev Anticancer Ther
; 13(9): 1089-108, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23919536
20.
Single-agent lenalidomide in patients with mantle-cell lymphoma who relapsed or progressed after or were refractory to bortezomib: phase II MCL-001 (EMERGE) study.
J Clin Oncol
; 31(29): 3688-95, 2013 Oct 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-24002500